Switch From Tacrolimus to Cyclosporine Microemulsion: Immunosuppressive Agents and Diabetes Management in Liver Transplant Recipients in Maintenance (DIALIVER)

NCT00171743 Phase 4 COMPLETED

The purpose of this study is to determine whether the switch from tacrolimus to cyclosporine microemulsion benefits post-transplant diabetes management (in terms of glycogenic control and insulin dosage) in stable liver transplant recipients.

Details

Lead sponsor	Novartis
Phase	Phase 4
Status	COMPLETED
Enrolment	47
Start date	2004-04
Completion	2006-01

Conditions

• Liver Transplant

Interventions

• Cyclosporine microemulsion